title: Complications of pelvic and para-aortic lymphadenectomy in patients with endometrial cancer.
abstract: The International Federation of Gynecology and Obstetrics (FIGO) changed the staging criteria for endometrial cancer in 1988 and adopted a surgical-pathological staging involving also pelvic and/or para-aortic lymphadenectomy. A total of 236 patients were treated for endometrial adenocarcinoma at Department B of the Gynecologic and Obstetrics Institute, University of Turin, between January 1976 and December 1995. Our protocol for surgical staging always entails pelvic and para-aortic lymphadenectomy and a simple total hysterectomy and bilateral adnexectomy with removal of the upper third of the vagina. The aim of this study was to carry out a retrospective evaluation of the morbidity in patients with endometrial cancer after surgical treatment, either TAH-BSO alone or TAH-BSO with pelvic and para-aortic lymphadenectomy.
authors.affiliation: Department B of Gynecology and Obstetrics Institute, University of Torino, Italy.
authors.forename: S
authors.initials: S
authors.lastname: Arduino
authors.forename: L
authors.initials: L
authors.lastname: Leo
authors.forename: G
authors.initials: G
authors.lastname: Febo
authors.forename: M
authors.initials: M
authors.lastname: Tessarolo
authors.forename: T
authors.initials: T
authors.lastname: Wierdis
authors.forename: A
authors.initials: A
authors.lastname: Lanza
mesh_terms: D000230:Adenocarcinoma / Q000401:mortality / Q000601:surgery*; D000368:Aged; D016889:Endometrial Neoplasms / Q000401:mortality / Q000601:surgery*; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007044:Hysterectomy / Q000009:adverse effects*; D015994:Incidence; D007431:Intraoperative Complications / Q000453:epidemiology; D007902:Length of Stay; D008197:Lymph Node Excision / Q000009:adverse effects*; D008207:Lymphatic Metastasis; D008875:Middle Aged; D009017:Morbidity; D010052:Ovariectomy / Q000009:adverse effects*; D010388:Pelvis; D011183:Postoperative Complications / Q000453:epidemiology; D011379:Prognosis; D012187:Retroperitoneal Space; D012189:Retrospective Studies; D012307:Risk Factors; D015996:Survival Rate